NeuroPace Inc (NPCE) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... [Yahoo! Finance]
Neuropace, Inc. (NPCE)
Company Research
Source: Yahoo! Finance
This article first appeared on GuruFocus Release Date: March 03, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript Positive Points NeuroPace Inc ( NASDAQ:NPCE ) reported strong quarterly revenue of $26.6 million, representing a 24% year-over-year growth. The RNS system revenue grew by 26% year-over-year, reflecting strong adoption and utilization. The company achieved a gross margin greater than 77%, with RNS gross margin exceeding 80%. NeuroPace Inc ( NASDAQ:NPCE ) delivered its second consecutive quarter of positive adjusted EBITDA and positive cash generation. The company is advancing its product pipeline with AI tools like Seizure ID, which is expected to enhance physician workflow and improve patient outcomes. Negative Points Revenue from Dixie Medical declined by 4% compared to the fourth quarter of 2024. The company reported a net loss of $2.7 million for the fourth quarter. Operating expenses incre
Show less
Read more
Impact Snapshot
Event Time:
NPCE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NPCE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NPCE alerts
High impacting Neuropace, Inc. news events
Weekly update
A roundup of the hottest topics
NPCE
News
- NeuroPace to Present at the Leerink Global Healthcare ConferenceBusiness Wire
- NeuroPace (NPCE) was upgraded by Cantor Fitzgerald to "strong-buy".MarketBeat
- Why NeuroPace Stock Was Inching Higher on Wednesday [Yahoo! Finance]Yahoo! Finance
- NeuroPace, Inc. (NPCE) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- NeuroPace reiterates $98M–$100M 2026 revenue target while advancing AI and IGE pipeline [Seeking Alpha]Seeking Alpha
NPCE
Earnings
- 3/3/26 - Beat
NPCE
Sec Filings
- 3/4/26 - Form 4
- 3/4/26 - Form 4
- 3/3/26 - Form S-8
- NPCE's page on the SEC website